Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
US Army
Mallinckrodt
Federal Trade Commission
Citi
Deloitte
Medtronic
Moodys
McKesson

Generated: November 20, 2018

DrugPatentWatch Database Preview

Drugs in Development Information for CC-223

« Back to Dashboard

US Patents for CC-223

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
CC-223 ➤ Sign Up Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway Signal Pharmaceuticals, LLC (San Diego, CA) ➤ Sign Up
CC-223 ➤ Sign Up Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway Signal Pharmaceuticals, LLC (San Diego, CA) ➤ Sign Up
CC-223 ➤ Sign Up Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/AKT pathway Signal Pharmaceuticals, LLC (San Diego, CA) ➤ Sign Up
CC-223 ➤ Sign Up Methods of synthesis and purification of heteroaryl compounds Signal Pharmaceuticals, LLC (San Diego, CA) ➤ Sign Up
CC-223 ➤ Sign Up Methods of synthesis and purification of heteroaryl compounds Signal Pharmaceuticals, LLC (San Diego, CA) ➤ Sign Up
CC-223 ➤ Sign Up Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors Signal Pharmaceuticals, LLC (San Diego, CA) ➤ Sign Up
CC-223 ➤ Sign Up Methods of synthesis and purification of heteroaryl compounds Signal Pharmaceuticals, LLC (San Diego, CA) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for CC-223

Drugname Country Document Number Estimated Expiration Related US Patent
CC-223 Argentina 073995 2028-10-27 ➤ Sign Up
CC-223 Australia 2009320137 2028-10-27 ➤ Sign Up
CC-223 Canada 2740975 2028-10-27 ➤ Sign Up
CC-223 Chile 2014000301 2028-10-27 ➤ Sign Up
CC-223 China 102245611 2028-10-27 ➤ Sign Up
CC-223 China 104725384 2028-10-27 ➤ Sign Up
CC-223 China 104744475 2028-10-27 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Queensland Health
QuintilesIMS
Mallinckrodt
Merck
Chinese Patent Office
Boehringer Ingelheim
Cipla
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.